Antimicrobial categories	Drugs μg/disc	Breakpoints (mm)			% Resistance
					Healthy stool		Patient stool with Gastroenteritis		Patient urine with UTI
		R≤	I	S≥	E. coli n = 24	Klebsiella n = 6	E. coli n = 18	Klebsiella n = 10	E. coli n = 32
β-lactamase inhibitors/Penicillins	AMC, 30	13	14 - 17	18	62.5	83.3	88.9	80	68.8
β-lactamase inhibitors/Penicillins	PRL, 100	13	14 - 16	17	50	IR	44.4	IR	12.5
Extended Spectrum 3rd generation cephalosporins	CTX, 30	22	23 - 25	26	58.3	50	55.5	60	50
Extended Spectrum 3rd generation cephalosporins	CAZ, 30	17	18 - 20	21	58.3	33.3	77.8	80	37.5
Aminoglycosides	AK, 30	14	15 - 16	17	25	33.3	22.2	0	6.3
Aminoglycosides	CN, 10	12	13 - 14	15	8.3	33.3	11.1	0	18.8
Quinolones/ Fluoroquinolones	CIP, 5	21	22 - 25	26	41.7	0	11.1	40	37.5
Quinolones/ Fluoroquinolones	LE, 5	16	17 - 20	21	16.7	0	22.2	40	18.8
Carbapenems	MEM, 10	19	20 - 22	23	16.7	0	0	0	12.5
Carbapenems	IPM, 10	19	20 - 22	23	0	0	0	0	0
Macrolides	AZM, 15	12	-	13	41.7	33.3	77.8	40	43.8
Tetracyclines	TE, 30	11	12 - 14	15	33.3	33.3	77.8	60	18.8
Chloramphenicol	C, 30	12	13 - 17	18	16.7	0	44.4	40	6.3
Nitrofurantoins	NIT, 300	14	15 - 16	17	33.3	33.3	11.1	0	25